Rigshospitalet

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Private

Established: 1757-03-30

Employees: 10K

Market Cap: -

Website: http://www.rigshospitalet.dk

Clinical Trials

Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus
Insulin Resistance
Dyslipidemia

Interventions: Dietary Supplement: High carbohydrate overfeeding
Behavioral: Exercise
Behavioral: Normal physical activity

First Posted Date: 2016-12-05

Last Posted Date: 2019-09-06

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 48

Registration Number: NCT02982408

Locations: 🇩🇰
Rigshospitalet, Denmark, Copenhagen, Capital Region, Denmark

Ultrasonography Versus Palpation for Identification of the Cricothyroid Membrane

Not Applicable

Conditions: Airway Obstruction

Interventions: Procedure: Marking of the cricothyroid membrane after Palpation
Other: Marking the cricothyroid membrane after ultrasound

First Posted Date: 2016-11-29

Last Posted Date: 2016-11-29

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 40

Registration Number: NCT02975791

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Phase 1

Conditions: Neuroendocrine Carcinoma
Breast Cancer
Ovarian Cancer

Interventions: Drug: Injection of 68Ga-NODAGA-E(c[RGDyK])2

First Posted Date: 2016-11-22

Last Posted Date: 2016-11-22

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 10

Registration Number: NCT02970786

Locations: 🇩🇰
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

Characterization of Epicardial and Pericardial Adipose Tissue in Coronary Artery Disease

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2016-11-17

Last Posted Date: 2020-11-27

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 28

Registration Number: NCT02965625

Locations: 🇩🇰
Centre for Physical Activity Research, Copenhagen, Denmark

uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2

Terminated

Conditions: Bone Metastases
Prostate Cancer Metastatic

Interventions: Drug: Injection of PET tracer 68Ga-NOTA-AE105
Device: PET/CT

First Posted Date: 2016-11-16

Last Posted Date: 2019-10-15

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 17

Registration Number: NCT02964988

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark

Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: 68Ga-NOTA-AE105

First Posted Date: 2016-11-16

Last Posted Date: 2022-11-03

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 57

Registration Number: NCT02965001

Locations: 🇩🇰
Departmen of Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Long Term Survivors of High-grade Glioma and Their Caregivers

Completed

Conditions: Brain Diseases
Quality of Life
Depression
Physical Impairment

Interventions: Other: no treatment

First Posted Date: 2016-11-16

Last Posted Date: 2020-06-04

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 13

Registration Number: NCT02965144

Locations: 🇩🇰
University hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark

uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

Phase 2

Conditions: Oropharyngeal Cancer
Head and Neck Neoplasms
Cancer of Mouth
Neoplasms by Site
Neoplasms
Oral Cancer

Interventions: Other: 68Ga-NOTA-AE105 PET/CT

First Posted Date: 2016-11-10

Last Posted Date: 2016-11-10

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 90

Registration Number: NCT02960724

Locations: 🇩🇰
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark

Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

Phase 2

Completed

Conditions: Primary Progressive Multiple Sclerosis

Interventions: Drug: Placebo
Drug: Dimethyl fumarate

First Posted Date: 2016-11-09

Last Posted Date: 2020-12-24

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 54

Registration Number: NCT02959658

Locations: 🇩🇰
Danish Multiple Sclerosis Center, Department of neurology, Copenhagen, Denmark

PROstaTe Cancer - Exercise-STudy (PRO-TEST)

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: High Intensity Interval Training
Behavioral: Usual Care Observational Control

First Posted Date: 2016-11-03

Last Posted Date: 2019-12-18

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 30

Registration Number: NCT02954783

Locations: 🇩🇰
Center for Physical Activity Research, Copenhagen University Hospital, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy